AvantGuard has been awarded a $325K NIH Phase I Grant for non-coating antimicrobial, anti-host deposition, anti-inflammatory urinary...

NEW YORK, May 11, 2023 /PRNewswire/ -- AvantGuard, a fast-growing company in the antimicrobial industry, announced today the successful...

AvantGuard, Inc. is pleased to announce a $1.7 million Phase II SBIR award from the National Institutes of Health (NIH) to continue...

ITHACA, N.Y., March 23, 2023 /PRNewswire/ -- AvantGuard, announced today the unveiling of its new brand identity as a transformative...

(Ithaca, NY) — Halomine™, Inc. , a pioneer in advanced technology for managing surfaces and providing long term protection against...

FORT MILL, S.C., June 29, 2021 (GLOBE NEWSWIRE) - Diversey Holdings, Ltd. (NASDAQ: DSEY), a leading provider of hygiene, infection...

$77k Investment for Rollout of HaloFilm™ (Ithaca, NY) — Halomine™, a start-up company developing a suite of novel, long-acting,...

$256K Award to Study Efficacy Against Coronavirus, Other Viruses (Ithaca, NY) — Halomine™, Inc., developer of a suite of novel,...

$225K Award Recognizes “Excellent Efficacy Against Pathogens” (Ithaca, NY) — Halomine™, Inc. today announced that it has received a...